Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma.
Mark R. Albertini,Zachary Scott Morris,Jacquelyn A. Hank,Erik Ranheim,Cindy L. Zuleger, Kimberly McDowell, Renae M. Quale, Molly Monson,Erin Clements, Tamara Koehn,Heather B. Neuman,Sharon M. Weber,Jennifer Racz,Mary Beth Henry,Emily Reinstad,KyungMann Kim,Stephen D. Gillies,Paul M. Sondel JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
